Ophthalmic Adaptive Optics (AO) Retinal Imaging System

The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland. Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 .

• NAICS334516
• PSC6640

No documents posted for this opportunity.